Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Deinove SA ALDEI.PA
$0.03
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
1134989.00000000
-
week52high
0.44
-
week52low
0.01
-
Revenue
367000
-
P/E TTM
0
-
Beta
0.79419700
-
EPS
-0.24000000
-
Last Dividend
0.00000000
-
Next Earnings Date
28 сент 2022 г. в 10:59
Описание компании
DEINOVE SA, a biotech company, discovers, develops, and produces compounds originating from microbials for the health, nutrition, and cosmetics industries worldwide. The company's antibiotic candidates include DNV3837, an antibiotic, which is in the Phase II clinical trial for the treatment of Clostridioides difficile infections. It also offers PHYT-N-Resist, an anti-aging active ingredient for cosmetics; Luminity, a carotenoid-based ingredient to absorb blue light and exceptional antioxidant properties; HEBELYS, a natural active ingredient produced by fermentation of Sphingomonas; and BIOME Oléoactif, which acts as a post-biotic extract with a prebiotic effect to balance the skin microbiota. In addition, the company develops a process for producing natural ingredients for animal feed. DEINOVE SA has partnership agreements primarily with bioMérieux, Naicons, Medpace, Institut Pasteur, Hallstar Group, Sharon Laboratories, Oléos-Hallstar, Greentech, and Avril. The company was founded in 2006 and is headquartered in Grabels, France.
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Свежие комментарии
Свежие комментарии